TOKYO -- IBM Japan and the University of Tokyo will work together to devise the most effective cancer treatments for individual patients using artificial intelligence, the first such attempt in Asia.
IBM Japan will collect the latest medical research and drug data from across the world on its state-of-the-art supercomputer Watson. The system has the cognitive ability to read language texts, allowing it to process an enormous amount of data in a very short period of time.
